Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
about
Implications of MMP9 for Blood Brain Barrier Disruption and Hemorrhagic Transformation Following Ischemic StrokeB-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysisBiomarkers for strokeProteomic and biomarker studies and neurological complications of pediatric sickle cell diseaseThe role of hs-CRP, D-dimer and fibrinogen in differentiating etiological subtypes of ischemic strokeCoordinated activation of the Rac-GAP β2-chimaerin by an atypical proline-rich domain and diacylglycerol.A biochemical marker panel in MRI-proven hyperacute ischemic stroke-a prospective study.Plasma brain natriuretic peptide as a surrogate marker for cardioembolic strokeStroke risk associated with balloon based catheter ablation for atrial fibrillation: Rationale and design of the MACPAF Study.Interpretation and use of natriuretic peptides in non-congestive heart failure settingsRisk factors and biomarkers of ischemic stroke in cancer patientsBNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular eventsHigh-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke.N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohortSignatures of cardioembolic and large-vessel ischemic stroke.Cardiac workup of ischemic stroke.Blood biomarkers in cardioembolic stroke.Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS)Biomarker panels in ischemic stroke.Correlation between Serum D-Dimer Level and Volume in Acute Ischemic StrokeThe renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage.Blood biomarkers of ischemic stroke.Prevention of cardioembolic stroke.Predictors of poor outcome in patients with acute cerebral infarctionBrain natriuretic peptide predicts functional outcome in ischemic strokeEmbolic Stroke Diagnosed by Elevated D-Dimer in a Patient With Negative TEE for Cardioembolic SourcePotential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke.Lessons from Metabonomics on the Neurobiology of Stroke.Blood biomarkers role in acute ischemic stroke patients: higher is worse or better?Plasma B-type natriuretic peptide level in patients with acute cerebral infarction according to infarction subtype and infarction volumeMultiple liquid chromatography separations and nanoESI-ion trap detection of plasma proteins in search of stroke biomarkers: A pilot study.Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapyEffects of Acute Stroke Serum on Non-Ischemic Cerebral and Mesenteric Vascular FunctionSerum soluble RAGE levels and carotid atherosclerosis: the Northern Manhattan Study (NOMAS).The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury.Molecular biomarkers in stroke diagnosis and prognosis.Plasma D-dimer levels are associated with stroke subtypes and infarction volume in patients with acute ischemic stroke.A bioclinical pattern for the early diagnosis of cardioembolic stroke.Clinical application of blood biomarkers in cerebrovascular disease.Inflammatory and neuroendocrine biomarkers of prognosis after ischemic stroke.
P2860
Q26766038-3C2C7601-B993-4F53-9DCA-F3AAA15769D1Q26861828-5E148F0E-6854-46E2-90FE-4C734097C206Q27004404-F1C615A3-7317-45C0-B138-6DCBD823DA17Q27027066-B21BC599-90D2-40D8-85ED-9E323B2EDEB1Q28543461-74A5E821-348F-4FCB-87A9-49EB2B8C87FDQ30009858-819FCBE1-AFAB-48AB-BD72-5B0E0AC03C2AQ31050144-2931BCED-2EE7-4E55-BAA6-D4B5D38AA45FQ33392414-EEC282B9-FCE6-43E6-A955-1B45C38FF818Q33642189-ED73152B-0F50-421B-8BD5-6F38FE6FAA93Q33670478-61568DBE-238C-433F-9DA2-216EA77D6B8EQ33765896-B5F15613-DDA2-4D73-B5A3-00CCF7FAA632Q33967122-8D45C880-6A3B-4FD2-A6A3-F234DE835B13Q34036010-2B5462D8-A258-4BCA-AB44-4C30B57CCA81Q34080669-D79A0168-970B-4A10-8C1F-ACFB342A0C38Q34257962-EDE5001D-EF08-4A42-B8AA-36D5944BB3D5Q34362863-5FFDC80E-9350-4F09-8EF1-4D6EA3FC0D9AQ34362880-274FDE64-CDFB-4AE3-8F53-531B0E0CFD87Q34949171-300CE02D-67E5-4381-837A-9935668416D7Q35125900-9D058CB5-01FE-4109-AB81-87C7A943CF6DQ35503036-377CC61A-AA72-437B-AB40-207E66EE4EB2Q35613257-EBD9BC68-8FE7-4852-8F08-192E9CFC071CQ35648087-F4FA5FB8-1AFF-46DB-8D22-417F3B7337A0Q35648111-DF86F604-C41C-467C-BFA7-19F8FE218771Q35675976-3F67F7E8-E454-4176-85DD-391E700716F2Q35693427-FA2F9B04-8796-4272-8EC2-8D4E09C8A621Q35927655-1D8959D7-CCFE-4403-892F-DC585EB6517AQ36155695-821A7C67-C699-46DA-AEC7-F7C0E8123AB9Q36323482-9070F0F0-577D-48AB-B6B7-8CEC0093C3D7Q36498530-E942F778-7621-4E28-9520-00B47E1AB1D4Q36501539-4BD33C4B-337F-427A-8E49-B97D63D23CD1Q36571761-D85EB63D-9EE2-40CA-AB44-78B94A8F488FQ36642014-3FD3D302-EB24-4950-BD36-DBAA08A98F50Q36642465-B4FDD3C3-1952-4437-98B8-7F1F97FD6D64Q36935766-73288955-293D-4101-AE56-77E9C491AAC6Q37154481-DCC17C0D-D2C0-4D2E-90B9-B12B6381D85AQ37408830-14DEE988-6C5C-437A-AD4E-F222EA1A5738Q37496144-B1F8FAB6-3B86-4516-8D98-EA000C56267AQ37657775-8E536C09-15B6-4444-BE49-52B1971A0A01Q37688066-B309B532-0745-46A2-8BAE-20A225ACF439Q37838426-484F0272-94CB-49B4-8F3E-581CBB97A6CB
P2860
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
@en
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
@nl
type
label
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
@en
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
@nl
prefLabel
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
@en
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
@nl
P2093
P50
P1433
P1476
Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers
@en
P2093
Anna Rosell
Carlos A Molina
Manolo Quintana
Mauricio E Palacios
Mila Perea-Gainza
Pilar Chacón
P304
P356
10.1161/STROKEAHA.107.505354
P407
P577
2008-06-05T00:00:00Z